| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1078.189 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.189/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189 |
| Version | 20231006 |
| Status | active |
| Date | 2023-10-06T01:03:19-04:00 |
| Name | SGLT2i |
| Title | SGLT2i |
| Realm | us |
| Authority | hl7 |
| Description | 2023-10-02 Added dapagliflozin/metformin combination (Xigduo) |
| Purpose | (Clinical Focus: Medications containing SLGT2 inhibitors.),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: RxCUIs for medications containing any of the following ingredients:
* bexaglifloxin
* canagliflozin
* dapagliflozin
* empagliflozin
* ertugliflozin),(Exclusion Criteria: None) |
FHIR